A long-term study by the Food and Drug Administration on MDMA-assisted therapy for PTSD patients is nearing completion. Phrase 3 trials started in November 2016. (National Institute on Drug Abuse)
Featured Photo Galleries
A long-term study by the Food and Drug Administration on MDMA-assisted therapy for PTSD patients is nearing completion. Phrase 3 trials started in November 2016. (National Institute on Drug Abuse)
